Baidu
map

血液科

订阅

MedSci主页 / 所有栏目 / 血液科

JCLA：地中海贫血对尼日利亚镰状细胞性贫血患儿临床及实验室参数的影响

2019-06-03 不详 网络

地中海贫血
关注

目前，关于地中海贫血对尼日利亚镰状细胞贫血(SCA)患者临床和实验室参数的影响，仍缺乏相关数据。本研究旨在确定尼日利亚SCA年轻患者中地中海贫血的患病率以及地中海贫血对实验室参数和临床表现的影响。 这是一项横断面回顾性研究，研究人员对100名SCA患者和63名对照组进行了研究。DNA研究证实了关于SCA的诊断。采用多重gap‐PCR方法进行地中海贫血基因分型。采用标准技术测定全血计数、血红蛋

目前，关于地中海贫血对尼日利亚镰状细胞贫血(SCA)患者临床和实验室参数的影响，仍缺乏相关数据。本研究旨在确定尼日利亚SCA年轻患者中地中海贫血的患病率以及地中海贫血对实验室参数和临床表现的影响。

这是一项横断面回顾性研究，研究人员对100名SCA患者和63名对照组进行了研究。DNA研究证实了关于SCA的诊断。采用多重gap‐PCR方法进行地中海贫血基因分型。采用标准技术测定全血计数、血红蛋白定量、血清乳酸脱氢酶(LDH)、胆红素等实验室指标。

研究人员在41个病例中确诊了(41.0%)α地中海贫血，与24例阴性对照相比，均是由于κbα球蛋白基因缺失所导致的。地中海贫血与患者频繁的骨痛危象、更高的血红蛋白浓度、红细胞计数和HbA2水平有关。相反，α地中海贫血患者微粒体积较低，微粒血红蛋白和白细胞计数(WBC) (P˂0.05)。其中6例(6.0%)腿部溃疡，无地中海贫血，P = 0.04。

本研究证实，地中海贫血与SCA共存对尼日利亚年轻SCA患者的临床和实验室表现均有显著影响。这种基因修饰剂的共存与骨痛危机增加，并可保护镰状腿溃疡的患者。

原始出处：

Oladele S. Olatunya, Dulcineia M. Albuquerque, Influence of alpha thalassemia on clinical and laboratory parameters among nigerian children with sickle cell anemia

本文系梅斯医学（MedSci）原创编译整理，转载需授权！


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1634511, encodeId=6a631634511bc, content=<a href='/topic/show?id=aa784e36406' target=_blank style='color:#2F92EE;'>#尼日利亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47364, encryptionId=aa784e36406, topicName=尼日利亚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Oct 25 11:36:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805170, encodeId=ec2f18051e053, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77906, encryptionId=3138e790655, topicName=细胞性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86b7385, createdName=lqrandywkz, createdTime=Tue May 12 18:36:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575501, encodeId=1f7e15e5501e7, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589631, encodeId=b168158963122, content=<a href='/topic/show?id=16d59686639' target=_blank style='color:#2F92EE;'>#镰状细胞性贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96866, encryptionId=16d59686639, topicName=镰状细胞性贫血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87f517763531, createdName=zhang92566, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615508, encodeId=f140161550860, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=)]
    2019-10-25 医者仁心

    #尼日利亚#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1634511, encodeId=6a631634511bc, content=<a href='/topic/show?id=aa784e36406' target=_blank style='color:#2F92EE;'>#尼日利亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47364, encryptionId=aa784e36406, topicName=尼日利亚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Oct 25 11:36:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805170, encodeId=ec2f18051e053, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77906, encryptionId=3138e790655, topicName=细胞性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86b7385, createdName=lqrandywkz, createdTime=Tue May 12 18:36:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575501, encodeId=1f7e15e5501e7, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589631, encodeId=b168158963122, content=<a href='/topic/show?id=16d59686639' target=_blank style='color:#2F92EE;'>#镰状细胞性贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96866, encryptionId=16d59686639, topicName=镰状细胞性贫血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87f517763531, createdName=zhang92566, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615508, encodeId=f140161550860, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=)]
    2020-05-12 lqrandywkz

    #细胞性#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1634511, encodeId=6a631634511bc, content=<a href='/topic/show?id=aa784e36406' target=_blank style='color:#2F92EE;'>#尼日利亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47364, encryptionId=aa784e36406, topicName=尼日利亚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Oct 25 11:36:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805170, encodeId=ec2f18051e053, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77906, encryptionId=3138e790655, topicName=细胞性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86b7385, createdName=lqrandywkz, createdTime=Tue May 12 18:36:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575501, encodeId=1f7e15e5501e7, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589631, encodeId=b168158963122, content=<a href='/topic/show?id=16d59686639' target=_blank style='color:#2F92EE;'>#镰状细胞性贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96866, encryptionId=16d59686639, topicName=镰状细胞性贫血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87f517763531, createdName=zhang92566, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615508, encodeId=f140161550860, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=)]
    2019-06-05 wgx311

    #地中海#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1634511, encodeId=6a631634511bc, content=<a href='/topic/show?id=aa784e36406' target=_blank style='color:#2F92EE;'>#尼日利亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47364, encryptionId=aa784e36406, topicName=尼日利亚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Oct 25 11:36:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805170, encodeId=ec2f18051e053, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77906, encryptionId=3138e790655, topicName=细胞性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86b7385, createdName=lqrandywkz, createdTime=Tue May 12 18:36:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575501, encodeId=1f7e15e5501e7, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589631, encodeId=b168158963122, content=<a href='/topic/show?id=16d59686639' target=_blank style='color:#2F92EE;'>#镰状细胞性贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96866, encryptionId=16d59686639, topicName=镰状细胞性贫血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87f517763531, createdName=zhang92566, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615508, encodeId=f140161550860, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=)]
    2019-06-05 zhang92566

    #镰状细胞性贫血#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1634511, encodeId=6a631634511bc, content=<a href='/topic/show?id=aa784e36406' target=_blank style='color:#2F92EE;'>#尼日利亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47364, encryptionId=aa784e36406, topicName=尼日利亚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Oct 25 11:36:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805170, encodeId=ec2f18051e053, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77906, encryptionId=3138e790655, topicName=细胞性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86b7385, createdName=lqrandywkz, createdTime=Tue May 12 18:36:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575501, encodeId=1f7e15e5501e7, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589631, encodeId=b168158963122, content=<a href='/topic/show?id=16d59686639' target=_blank style='color:#2F92EE;'>#镰状细胞性贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96866, encryptionId=16d59686639, topicName=镰状细胞性贫血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87f517763531, createdName=zhang92566, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615508, encodeId=f140161550860, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96865, encryptionId=280196865f7, topicName=镰状细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb4819654385, createdName=1508842480_96220443, createdTime=Wed Jun 05 13:36:00 CST 2019, time=2019-06-05, status=1, ipAttribution=)]
    2019-06-05 1508842480_96220443

    #镰状细胞#

    0

相关资讯

NEJM：人体试验疗效达100%！基因治疗突破成果

自从人类开始基因组计划之后，科学家们一直希望有一天可以通过编辑修饰患者的致病基因从根本上治愈疾病。现在，一个国际临床研究小组取得了初步的成功，他们使用基因疗法治疗输血依赖型β-地中海贫血，1-2期临床试验取得100%疗效。

非输血依赖型地中海贫血诊断与治疗中国专家共识（2018年版）

依据临床表现，地贫分为重型地贫和非输血依赖型地贫(NTDT)。NTDT是指一组不需要输血或者仅在感染、手术、妊娠、生长发育迟缓等特殊情况下需要输血的地贫类型，包括不需要输血的地贫α-地贫携带者、轻型β-地贫、HbC/β-一地贫)、偶尔需要输血的地贫(缺失型HbH病、轻度异常血红蛋白E/β-地贫)、需要间歇性输血的地贫(非缺失型HbH病、中间型β-地贫、中度异常血红蛋白E/β-地贫)。近十年来，对N

Haematologica：当地中海贫血遭遇铁尘肺

输血依赖的地中海贫血致死的主要原因是Cardiosiderosis（心脏-铁尘肺）。血浆非转铁蛋白结合铁(non-transferrin bound iron, NTBI)和其氧化还原的活性组分，不稳定的血浆铁离子，是cardiosiderosis中的铁负荷的主要来源。发表在最新一期的Haematologica上的一项研究，研究人员在73例有/无cardiosiderosis的患者中探讨了其相关的

国家卫健委：地中海贫血防治需进行三级预防

5月8日是第26个“世界地贫日”。地贫全称为地中海贫血，是我国南方地区高发的一种遗传病，严重影响儿童健康和出生人口素质。国家卫健委提示，地中海贫血难治可防，防治地中海贫血需采取婚前孕前预防、产前预防和地贫患儿早诊早治的三级预防策略。这是记者8日从国家卫健委举办的“2019年世界地贫日主题宣传活动”广东主场活动上获悉的。地贫是一种因基因缺失或突变导致的遗传性贫血。我国长江以南的广西、广东、海南等省份

JCLA：地中海贫血的实验室诊断

目前，临床上关于如何区分重型地中海贫血和中度地中海贫血，由于它们在临床上的表现仍存自一定的难度，因此需要制定一个绝对的分类标准。本研究调查了原发性和继发性遗传修饰因子，通过形成地中海贫血患者不同的基因突变组合，并将其与重度地中海贫血患者进行比较，从而得出实验室证据。

CTX001获得FDA快速通道资格用于治疗镰状细胞病

CRISPR治疗公司和Vertex制药公司近日宣布，美国食品和药品管理局（FDA）已授予CTX001快速通道资格用于治疗镰状细胞病（SCD）。CTX001是针对患有严重血红蛋白病患者的研究性、自体性、CRISPR基因编辑的造血干细胞疗法。

Baidu
map
Baidu
map
Baidu
map